July 8, 2020
July 8, 2020
Sema4 Introduces “Sema4 Signal™”, a New Family of Products and Services Delivering Data-driven Precision Oncology Solutions
Sema4, a patient-centered health intelligence company, today announced the launch of Sema4 Signal™, a new family of products and services providing data-driven precision oncology... Read More
July 8, 2020
Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical
Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd., a member of the Roche Group, and has applied... Read More
July 7, 2020
University of Glasgow Awarded £38M to Deliver Game-Changing Precision Medicine Project
The University of Glasgow has been awarded £38m to create the Precision Medicine Living Lab – an internationally leading project focused on translating cutting-edge... Read More
July 1, 2020
PFIZER AND BIONTECH ANNOUNCE EARLY POSITIVE DATA FROM AN ONGOING PHASE 1/2 STUDY OF MRNA-BASED VACCINE CANDIDATE AGAINST SARS-COV-2
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced preliminary data from the most advanced of four investigational vaccine candidates from their... Read More
July 1, 2020
Genome Medical Raises $14 Million to Expand Virtual Clinical Genetics Care and Accelerate Telemedicine Technology Development
Genome Medical today announced that it has raised $14 million to expand its clinical genetics care and operations. The funds will specifically support the... Read More
July 1, 2020
Vidence, LLC Launched to Set Standard for High-Quality Cancer Data, Research and Analytics
Vidence, LLC, an oncology informatics company, was officially launched today as an independent entity to provide the world’s leading cancer researchers, innovators and providers... Read More
July 1, 2020
New Artificial Intelligence Based Cancer Clinical Trial Finder Mobile App
The SYNERGY-AI Cancer Clinical Trial Finder app gives cancer patients access to new treatment options that are being approved by the FDA so that... Read More
July 1, 2020
Quantabio RT-qPCR ToughMix Given Expanded Role in CDC COVID-19 Testing Protocol
Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced... Read More
June 23, 2020
WuXi NextCODE Restructures and Becomes Genuity Science
WuXi NextCODE today announced plans to restructure its operations and governance in order to best position the company for future growth, ground-breaking offerings for... Read More
June 23, 2020
Thermo Fisher Scientific and Daiichi Sankyo to Co-Develop Global Companion Diagnostic for Patients with Non-Small Cell Lung Cancer
– Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will... Read More
June 22, 2020
Taconic Biosciences to Distribute Critical COVID-19 Mouse Model
Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an exclusive agreement with the University of Texas Medical Branch at... Read More
June 22, 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Invitae (NYSE: NVTA), a leading genetics company, and ArcherDX, a leading genomics analysis company democratizing precision oncology, today announced the companies have entered into... Read More
June 18, 2020
Rady Children’s Shows Genomic Sequencing for Infants in Intensive Care Yields Life-Changing Benefits and Medical Cost Savings
In a pilot study funded by the State of California, Rady Children’s Hospital-San Diego demonstrated that a rapid precision medicine program for critically ill... Read More
June 18, 2020
GNS Healthcare and Multiple Myeloma Research Foundation (MMRF) Announce a Five-Year Collaboration to Advance Precision Medicine
GNS Healthcare and the Multiple Myeloma Research Foundation (MMRF) today announced a five-year partnership to leverage the longitudinal multi-modal patient registry data from the... Read More
June 18, 2020
Novartis Cosentyx® receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis
Novartis, a leader in rheumatology and immuno-dermatology, today announced that the US Food and Drug Administration (FDA) has approved Cosentyx® (secukinumab) for the treatment... Read More
June 18, 2020
FoundationOne®CDx Receives FDA Approval as the First Companion Diagnostic to Identify Advanced Cancer Patients with Solid Tumors that are Tumor Mutational Burden-High (TMB-H) and Appropriate for Immunotherapy Treatment with KEYTRUDA® (pembrolizumab)
Foundation Medicine, Inc., has announced that the U.S. Food and Drug Administration (FDA) approved FoundationOne®CDx as a companion diagnostic for KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1... Read More
June 16, 2020
FDA Grants Breakthrough Device Designation to Thermo Fisher Scientific’s Oncomine Precision Assay to Identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Thermo Fisher Scientific’s Oncomine Precision Assay to identify low-grade glioma (LGG)... Read More
June 16, 2020
Active Motif Announces New Report Describing Advancements in Generation and Characterization of Their Recombinant Human COVID-19 Antibodies with Qualities that Make Them Ideal for Use in Diagnostics and Therapeutics
Active Motif, a company with the vision of bringing the field of epigenetics into personalized medicine, announces access to a pre-print publication associated with... Read More
June 11, 2020
Utah Cancer Specialists Implements XIFIN VisualStrata to Provide Care Teams with Improved Data Insights
Award-winning precision medicine informatics platform integrates data from disparate systems to provide clinicians with greater patient insights and supports value-based care initiatives Precision medicine... Read More
June 11, 2020
AbbVie and Genmab Announce Broad Oncology Collaboration
AbbVie and Genmab A/S announced that AbbVie and Genmab have signed a broad collaboration agreement to jointly develop and commercialize three of Genmab’s early-stage... Read More
June 10, 2020
Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals
Thermo Fisher Scientific have announced that it has expanded its strategic partnership with Agios Pharmaceuticals by adding the co-development of a second companion diagnostic... Read More
June 5, 2020
Seven Bridges Announces International Collaboration Focused on Personalized Treatment for Kids with Cancer
Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced a collaborative partnership between The Gabriella Miller Kids First Data Resource Center (Kids First DRC),... Read More
June 5, 2020
Precision Medicine and Diagnostics Expert Hakan Sakul, Ph.D., of Pfizer Joins the Progentec Board of Directors
Progentec, a leader in next-gen diagnostics and digital technologies for the management of autoimmune diseases, announced today that Hakan Sakul, Ph.D., Vice President and... Read More
May 29, 2020
Bristol Myers Squibb Receives European Commission Approval for Zeposia (ozanimod) for the Treatment of Adult Patients with Relapsing Remitting Multiple Sclerosis with Active Disease
-Bristol Myers Squibb has announced that the European Commission (EC) has approved Zeposia (ozanimod) for the treatment of adult patients with relapsing remitting multiple... Read More
Tweets
Only 72 hours left to register to hear how Texas Oncology is keeping up with Precision Medicine advances… https://t.co/WuuWhs2XJy, - New post: Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases https://t.co/oCMkrh10dL,
- New post: Sema4 Introduces “Sema4 Signal™”, a New Family of Products and Services Delivering Data-driven Precision O https://t.co/IbcX78peOv,